Medical device manufacturing is a risky business. When things go wrong with a medical device, there is a lot at stake. At the very least, it can be expensive and disruptive for your company. At the worst, it can cause patient injury or even death.
So how do you evaluate and manage risk? ISO 14971 standardizes risk management procedures and protocols for medical device manufacturers. In this white paper, we’ll take a deep dive into risk/benefit analysis, ISO 14971 requirements, and much more, including:
- How does ISO 14971 define risk/benefit analysis?
- What are the differences between ISO 14971:2007 and EN ISO 14971:2012?
- What is a data/literature review?
- What are some examples of quantitative risk/benefit methodologies?
Learn all this and much more in this 9-page white paper.
About the Author
Michael Dun, RAC: Michael Dun is the Australia Country Manager and Director at Emergo. He has more than 13 years of experience in quality systems, auditing, regulatory affairs, and research and development across the biotechnology, IVD and medical device manufacturing and services industries. His areas of expertise include QMS implementation and audits, risk management, and device registration and documentation in the US, EU, Brazil, and Australia.